I did a quick search on cannot afford medication help and found a bunch of random websites with links to other places and ideas. Here are a few:
AARP might have something. Looks like Texas has a kidney program, but might poke around there more and look.
http://www.aarp.org/bulletin/prescription/statebystate.htmlHere is an interesting website I found with links to other programs.
http://www.kybaptist.org/kbc/welcome.nsf/pages/annuityreliefPatient assistance programs are run by pharmaceutical companies to provide free medications to people who cannot afford to buy their medicine. RxAssist offers a comprehensive database of these patient assistance programs, as well as practical tools, news, and articles so that health care professionals and patients can find the information they need. All in one place.
http://www.rxassist.org/I know that you said it costs more than they make a yr so this wouldn't work, but it might eventually help if they can find a lower cost place. Look into pill splitting, buy pill of double dose, then split in 1/2 to take as this is usually much cheaper. More info from another webpage.
http://depression.about.com/cs/drugindex/ht/Pill_Splitting.htm
ttp://www.tysabri.com/
WARNING
TYSABRI® increases the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability. Although the cases of PML were limited to patients with recent or concomitant exposure to immunomodulators or immunosuppressants, there were too few cases to rule out the possibility that PML may occur with TYSABRI® monotherapy.
* Because of the risk of PML, TYSABRI® is available only through a special restricted distribution program called the TOUCH™ Prescribing Program. Under the TOUCH™ Prescribing Program, only prescribers, infusion centers, and pharmacies associated with infusion centers registered with the program are able to prescribe, distribute, or infuse the product. In addition, TYSABRI® must be administered only to patients who are enrolled in and meet all the conditions of the TOUCH™ Prescribing Program (see WARNINGS, Progressive Multifocal Leukoencephalopathy; and WARNINGS, Prescribing, Distribution, and Administration Program for TYSABRI®).
* Healthcare professionals should monitor patients on TYSABRI® for any new sign or symptom that may be suggestive of PML. TYSABRI® dosing should be withheld immediately at the first sign or symptom suggestive of PML. For diagnosis, an evaluation that includes a gadolinium-enhanced magnetic resonance imaging (MRI) scan of the brain and, when indicated, cerebrospinal fluid analysis for JC viral DNA are recommended (see CONTRAINDICATIONS and WARNINGS, Progressive Multifocal Leukoencephalopathy).